The Ethical and Practical Issues of Market Exclusivity for Naturally Derived Dermatologic Medications: The Case of Cantharidin.
New dermatologic therapies derived from long-used natural substances can enter the market at prices far above previously available compounded or imported formulations, once they receive United States Food and Drug Administration (FDA) approval. Patent protection is often blamed for this shift, but the mechanism at work...